Balyasny Asset Management »

Astria Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Astria Therapeutics (ATXS) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $462k 51k 9.10
2024-03-31 $531k 38k 14.08
2023-03-31 $6.5M 486k 13.30

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Mastercard Incorporated Cl A Call Option (MA)
Hess Call Option (HES)
Lockheed Martin Corporation Call Option (LMT)
Endeavor Group Hldgs Cl A Com Put Option (EDR)

View all positions for Balyasny Asset Management

Top funds holding Astria Therapeutics

Perceptive Advisors
RA Capital Management
Vestal Point Capital
Fairmount Funds Management
BlackRock
BlackRock
VR Adviser
TCG Crossover Management
Vanguard Group
State Street Corporation
Driehaus Capital Management
Geode Capital Management
Citadel Advisors
Affinity Asset Advisors
Nantahala Capital Management

View all funds holding Astria Therapeutics